ABVC BioPharma, Inc.
ABVCBiotechnology
$1.04−4.59%As of Oct 29vs prior close
- Market cap
- $27.8M
- P/E (TTM)
- –
- From 52W high
- −65.22%
- EPS (LTM)
- -$0.39
- Revenue (LTM)
- $296K
- Net margin
- -2671.81%
Nomior Score
20
Distressed LaggardBottom 7% of the scored universe
Growth—
Quality33
Value—
Momentum13
Resilience22
Growth
+70.89%revenue a year over 7 fiscal years
YE18 $7KLTM $296K
Connections
Revenue to profitQ3 YE25
The operating loss was 247% of revenue.
Who owns it
1fund